Insmed Inc logo

Insmed Inc

NEW
NAS:INSM (USA)   Ordinary Shares
$ 67.28 -3.015 (-4.29%) 03:59 PM EST
At Loss
P/B:
292.26
Market Cap:
$ 11.55B
Enterprise V:
$ 12.05B
Volume:
2.43M
Avg Vol (2M):
1.46M
Trade In:
Volume:
2.43M
At Loss
Avg Vol (2M):
1.46M

Business Description

Insmed Inc logo
Insmed Inc
NAICS : 325412 SIC : 2834
ISIN : US4576693075

Share Class Description:

INSM: Ordinary Shares
Description
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
Name Current Vs Industry Vs History
Cash-To-Debt 1.02
Equity-to-Asset 0.02
Debt-to-Equity 31.36
Debt-to-EBITDA -1.72
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.53
Distress
Grey
Safe
Beneish M-Score -2.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.47
9-Day RSI 38.52
14-Day RSI 42.11
6-1 Month Momentum % 195.31
12-1 Month Momentum % 206.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.71
Quick Ratio 2.53
Cash Ratio 2.38
Days Inventory 408.35
Days Sales Outstanding 41.14
Days Payable 279.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.9
Shareholder Yield % -0.93

Financials (Next Earnings Date:2024-10-31)

INSM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:INSM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Insmed Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 328.605
EPS (TTM) ($) -5.39
Beta 0.95
Volatility % 125.36
14-Day RSI 42.11
14-Day ATR ($) 2.057238
20-Day SMA ($) 72.537
12-1 Month Momentum % 206.72
52-Week Range ($) 21.92 - 80.53
Shares Outstanding (Mil) 171.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Insmed Inc Filings

Filing Date Document Date Form
No Filing Data

Insmed Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Insmed Inc Frequently Asked Questions

What is Insmed Inc(INSM)'s stock price today?
The current price of INSM is $67.28. The 52 week high of INSM is $80.53 and 52 week low is $21.92.
When is next earnings date of Insmed Inc(INSM)?
The next earnings date of Insmed Inc(INSM) is 2024-10-31.
Does Insmed Inc(INSM) pay dividends? If so, how much?
Insmed Inc(INSM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1